抗小鼠CD8a单抗（克隆号YTS 169.4）引用文献
抗小鼠CD8a单克隆抗体（克隆号YTS 169.4）引用文献如下：
1. CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
2. RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
3. P3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties
4.Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
5.Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models
6.Repeated dosing improves oncolytic rhabdovirus therapy in mice via interactions with intravascular monocytes
7.Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells
8.Targeting leucine-rich repeat serine/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy
9.Dendritic cells direct circadian anti-tumour immune responses
10.Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors
11.Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes
12.Decorin Potentiates Interferon-γ Activity in a Model of Allergic Inflammation
13.Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1
14.The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer
15.Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling
16.The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses
17.Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers
18.Murine Model of Interstitial Cytomegalovirus Pneumonia in Syngeneic Bone Marrow Transplantation: Persistence of Protective Pulmonary CD8-T-Cell Infiltrates after Clearance of Acute Infection
19.Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy
20.A cytotoxic T cell inspired oncolytic nanosystem promotes lytic cell death by lipid peroxidation and elicits antitumor immune responses
……
Syd Labs抗小鼠CD8a重组抗体（克隆号YTS 169.4）：
Syd Labs 重组抗小鼠CD8a单克隆抗体（克隆号YTS 169.4），大鼠IgG2b Kappa，体内实验级（In Vivo Grade Recombinant Anti-Mouse CD8a Monoclonal Antibody (Clone YTS 169.4), Rat IgG2b Kappa，货号：PA007166.r2b）是用哺乳动物细胞生产的重组抗体，从大鼠抗小鼠CD8a单克隆抗体(克隆号:YTS 169.4)可变区序列中提取，可用于蛋白质印迹、免疫组织化学（IHC）、流式细胞术（FC）和体内CD8+T细胞耗竭（消耗）等研究。
如果需要了解更多有关Syd Labs 重组抗小鼠CD8a单抗(克隆号YTS 169.4)信息，比如Syd Labs 抗小鼠CD8a单抗使用说明等资料，欢迎联系多找找获取。
特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。